Sangamo Therapeutics
SGMO
SGMO
103 hedge funds and large institutions have $48.4M invested in Sangamo Therapeutics in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 36 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
63% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 40
66% less call options, than puts
Call options by funds: $525K | Put options by funds: $1.54M
Holders
103
Holding in Top 10
–
Calls
$525K
Puts
$1.54M
Top Buyers
| 1 | +$1.55M | |
| 2 | +$629K | |
| 3 | +$236K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$213K |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
+$209K |
Top Sellers
| 1 | -$5.04M | |
| 2 | -$1.99M | |
| 3 | -$1.63M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.28M |
| 5 |
Goldman Sachs
New York
|
-$1.1M |